Previous close | 1.0000 |
Open | 1.0000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 57.50 |
Expiry date | 2025-05-16 |
Day's range | 1.0000 - 1.0000 |
Contract range | N/A |
Volume | |
Open interest | N/A |
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....
It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...